Assessment of new drug potential using publicly available data

KEYWORDS: scRNA-Seq & bulk RNA-seq | Public datasets | Neurodegenerative disorder


A customer wanted to assess the potential of a new drug for a range of possible applications and assess the applicability of Alzheimer’s in vivo model for other neurological disorders.


BISC Global performed data mining of public data repositories, targeted gene expression analysis to determine a list of potential genes, gene clusters and pathways of interest. After performing phenotype linkage, BISC Global was able to establish a list of phenotypes most likely to respond well to its drugs.


BISC Global was able to use existing data to reduce the customer’s clinical trial costs and perform more targeted new clinical trials for its new drugs.

Check our other Resources:

Contact us to discuss your project

    I agree to the privacy policy